| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 12/10/2002 | US6492129 Fragments comprising the n-terminal region of connective tissue growth factor (ctgf); screening for inhibitors or stimulators of ctgf |
| 12/10/2002 | US6492126 Compositions and methods for the treatment and diagnosis of cardiovascular disease |
| 12/10/2002 | US6492125 Method to assess library X library interactions |
| 12/10/2002 | US6492123 Polypeptides comprising a first domain of an immunoglobulin heavy chain variable region, and a second domain of an immunoglobulin light chain variable region, linked but incapable of associating with each other; assay for antigen |
| 12/10/2002 | US6492122 Determining concentration of preferential nucleotide sequences in sample; obtain nucleotide sequences, amplify, hybridize with amplicons, detect and quantitate hybridization products |
| 12/10/2002 | US6492119 Film-shaped material, which is not apt to suffer from bending and creasing, is used as a base material, such that the macro array is easy to process |
| 12/10/2002 | US6492118 Methods of immobilizing ligands on solid supports |
| 12/10/2002 | US6492117 A cys2 his2 (cysteine2 histidine 2) zinc finger polypeptide that binds to a telomeric nucleic acid, a g-quadruplex nucleic acid, or a g-quartet nucleic acid; manipulating telomeres in vivo |
| 12/10/2002 | US6492115 Genetic typing of the human cytochrome P450 2A6 gene and related materials and methods |
| 12/10/2002 | US6492114 Generating nucleotide sequences from seed oil; extract nucleotide sequences from seed oil, mix with separation fluid, recover preferential nucleotide sequences |
| 12/10/2002 | US6492112 Mitogen-activated protein kinase kinase 7 (MKK7) |
| 12/10/2002 | US6492111 Oligonucleotides identiphores are caused to bind specifically to target nucleic acid which is predictive of a disease state such as cancer within cells, and are detected by spectrum analysis |
| 12/10/2002 | US6492107 Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| 12/10/2002 | US6492104 EIA test using nondenatured HIV antigen for early detection of HIV infection |
| 12/10/2002 | US6491943 Method for treating an allergic or inflammatory disease |
| 12/10/2002 | US6491926 35 kD tumor associated protein antigen: uses and methods of detection |
| 12/10/2002 | US6491924 Sequence of at least 5 consecutive amino acids in the polypeptide of seq id no: 1 |
| 12/10/2002 | US6491920 Polypeptides and DNA encoding same |
| 12/10/2002 | US6491915 Anti-CCR2 antibodies and methods of use therefor |
| 12/10/2002 | US6491908 Selective elimination of T cells that recognize specific preselected targets |
| 12/10/2002 | US6491907 Genetic engineered chimera particles comprising capsids from adeno-associated virus and genome inverted terminal repeat sequences as vectors for supplying and expressing nucleotide sequence in cells |
| 12/10/2002 | US6491869 Method for preparing assay supports having an ordered set of reaction zones |
| 12/10/2002 | US6491821 System and method for performing polynucleotide separations using liquid chromatography |
| 12/10/2002 | CA2257118C Recombinant blood-coagulation proteases |
| 12/10/2002 | CA2212150C Monoclonal antibodies for human osteogenic cell surface antigens |
| 12/10/2002 | CA2196085C Mhc complexes and uses thereof |
| 12/10/2002 | CA2114015C Recombinant antibodies for human therapy |
| 12/10/2002 | CA2088574C Process for producing enzymes having superoxide dismutase activity, novel superoxide dismutase enzymes and novel pharmaceutical compositions comprising enzymes having superoxide dismutase activity |
| 12/10/2002 | CA2085127C Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease |
| 12/10/2002 | CA2080182C Nuclear inhibitor i-92 and its use for the production of a medicament |
| 12/10/2002 | CA2077764C Antibody to pacap and use thereof |
| 12/10/2002 | CA2047290C Recombinant marek's disease virus |
| 12/09/2002 | WO2001096595A2 Method for the detection of influenza a/b viruses in saliva |
| 12/08/2002 | WO2003000892A1 Gene encoding b protein |
| 12/08/2002 | CA2398093A1 Gene encoding protein b |
| 12/08/2002 | CA2365662A1 Transgenic rice plant and its family with environmental stress resistant by proline accumulation of high level and its production |
| 12/05/2002 | WO2002097433A1 Use of duckweed in high throughput screening |
| 12/05/2002 | WO2002097395A2 P-cadherin as a target for anti-cancer therapy |
| 12/05/2002 | WO2002097390A2 A quantitative hybridization assay for the analysis of nucleic acid |
| 12/05/2002 | WO2002097137A1 Light controlled gene expression utilizing heterologous phytochromes |
| 12/05/2002 | WO2002097135A1 Accurate and efficient quantification of dna sensitivity by real-time pcr |
| 12/05/2002 | WO2002097133A1 Antisense modulation of phospholipase a2, group iia (synovial) expression |
| 12/05/2002 | WO2002097132A2 Nucleic acid detection method |
| 12/05/2002 | WO2002097130A2 Microstructures and use thereof for the directed evolution of biomolecules |
| 12/05/2002 | WO2002097126A2 Method for detecting gram-positive bacteria having a high gc content |
| 12/05/2002 | WO2002097125A2 Tools for the diagnosis, molecular definition and development of treatment of chronic inflammatory joint diseases |
| 12/05/2002 | WO2002097124A1 Pharmacological applications of mitochondrial dna assays |
| 12/05/2002 | WO2002097120A1 Attractin/mahogany-like polypeptides, polynucleotides, antibodies and methods of use thereof |
| 12/05/2002 | WO2002097116A2 Delivery system for nucleic acids |
| 12/05/2002 | WO2002097114A2 Nucleic acid treatment of diseases or conditions related to levels of ras, her2 and hiv |
| 12/05/2002 | WO2002097110A2 TUMOR ENDOTHELIAL MARKER 7α MOLECULES AND USES THEREOF |
| 12/05/2002 | WO2002097108A2 Antisense modulation of dual specific phosphatase 5 expression |
| 12/05/2002 | WO2002097104A1 Pseudotyping vih-1 vectors with the aid of rhabdovirus envelopes |
| 12/05/2002 | WO2002097103A2 Constitutive plant promotor |
| 12/05/2002 | WO2002097102A2 Modification of plant genomes by inducible site-specific recombination of trans genes |
| 12/05/2002 | WO2002097101A1 Transgenic plants with reduced adenylate kinase activity showing an increased accumulation of starch |
| 12/05/2002 | WO2002097100A2 Cloning vectors for homologous recombination and method using same |
| 12/05/2002 | WO2002097099A1 Regulated expression of ghrh |
| 12/05/2002 | WO2002097098A1 Vector for lactic acid bacteria and method for expressing ferritin in the lactic bacteria |
| 12/05/2002 | WO2002097097A2 Compositions and methods of increasing stress tolerance in plants |
| 12/05/2002 | WO2002097096A2 Nucleotide sequences which code for the metd gene |
| 12/05/2002 | WO2002097095A1 Novel human transporter proteins and polynucleotides encoding the same |
| 12/05/2002 | WO2002097094A1 Bcl-2-modifying factor (bmf) sequences and their use in modulating apoptosis |
| 12/05/2002 | WO2002097091A1 Generation of hcv-like particles and chimeric hcv virus |
| 12/05/2002 | WO2002097087A1 Method of expressing foreign gene in kidney |
| 12/05/2002 | WO2002097085A2 Callus specific plant promoters |
| 12/05/2002 | WO2002097083A1 Method of extending long-chain dna |
| 12/05/2002 | WO2002097082A2 Engineered biosynthesis of novel polyenes |
| 12/05/2002 | WO2002097081A2 Method to generate non virulent microorganisms from pathogenic ones trough permanent genetic modification of their biological membrane for vaccine production |
| 12/05/2002 | WO2002097080A2 Amplification vectors based on trans-splicing |
| 12/05/2002 | WO2002097079A2 Gene encoding molecular motor protein and diagnosis method for the disease related to the gene |
| 12/05/2002 | WO2002097078A1 Compositions and methods for random nucleic acid mutagenisis |
| 12/05/2002 | WO2002097077A1 Method of preparing sucrose phosphorylase |
| 12/05/2002 | WO2002097075A2 Capping enzyme of flavivirus and utilization of this protein in a process to test drugs with antiviral properties |
| 12/05/2002 | WO2002097065A2 Remodeling of somatic nuclei upon addition of pluripotent cell extracts |
| 12/05/2002 | WO2002097063A1 Production of bioavailable folic acid |
| 12/05/2002 | WO2002097062A2 Recombinant narbonolide polyketide synthase |
| 12/05/2002 | WO2002097060A2 Carbohydrate-associated proteins |
| 12/05/2002 | WO2002097059A2 Chromosome-based platforms |
| 12/05/2002 | WO2002097056A2 Method for generating replication defective viral vectors that are helper free |
| 12/05/2002 | WO2002097051A2 Protein arrays and methods and systems for producing the same |
| 12/05/2002 | WO2002097050A2 Novel estrogen receptor ligand binding domain variants and novel ligands and pharmaceutical compositions |
| 12/05/2002 | WO2002097049A2 Compositions and methods for binding agglomeration proteins |
| 12/05/2002 | WO2002097047A2 Compositions and methods for the inference of pigmentation traits |
| 12/05/2002 | WO2002097046A2 B7 related protein-2 molecules and uses thereof |
| 12/05/2002 | WO2002097044A2 Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| 12/05/2002 | WO2002097043A2 Wnv core protein/capsid interacting protein and uses of the same |
| 12/05/2002 | WO2002097040A2 Methods for the identification of inhibitors of pectin esterase expression or activity in plants |
| 12/05/2002 | WO2002097039A2 Novel human hydroxylases and polynucleotides encoding the same |
| 12/05/2002 | WO2002097037A2 Melanin-concentrating hormone analogs |
| 12/05/2002 | WO2002097035A2 Secreted proteins |
| 12/05/2002 | WO2002097032A2 Proteins associated with cell growth, differentiation, and death |
| 12/05/2002 | WO2002097031A2 Molecules for diagnostics and therapeutics |
| 12/05/2002 | WO2002097030A2 Peptides derived from neural thread proteins and their medical use |
| 12/05/2002 | WO2002096952A2 Conjugate of a transport protein and a protein for modulation of notch signalling |
| 12/05/2002 | WO2002096951A1 Molecules for disease detection and treatment |
| 12/05/2002 | WO2002096948A2 Engineered tetravalent antibodies and methods of use |
| 12/05/2002 | WO2002096947A2 The lectin-like domain of thrombomodulin and its therapeutic use |
| 12/05/2002 | WO2002096946A1 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy30 |
| 12/05/2002 | WO2002096944A2 New heterotetrameric potassium channels and uses thereof |